AI

Treatment Recommendations

Compare AI-suggested treatment plans for Grace Karimu

Medications Lifestyle Procedures Follow-up
Parameter
Amlodipine 5mg once daily
Lisinopril 10mg once daily
Hydrochlorothiazide 25mg once daily
Drug Class CCB ACE Inhibitor Thiazide Diuretic
Efficacy Score
88%
82%
74%
Side Effects Peripheral edema, flushing, dizziness Dry cough, hyperkalemia, dizziness Hypokalemia, hyperuricemia, photosensitivity
Contraindications Severe aortic stenosis, cardiogenic shock Bilateral renal artery stenosis, pregnancy, angioedema Anuria, severe renal impairment, sulfonamide allergy
Dosage 5mg PO once daily, may increase to 10mg 10mg PO once daily, may titrate to 40mg 25mg PO once daily, max 50mg
Clinical Evidence Level A

Based on JNC-8 guidelines and SPRINT trial data. Amlodipine demonstrated superior systolic BP reduction in the ALLHAT trial for patients with metabolic syndrome.

Source: ALLHAT, SPRINT, JNC-8 Guidelines
Drug Interactions Safe

Metformin 500mg interaction check completed. No significant drug-drug interactions identified with any of the three proposed antihypertensive agents.

Checked against current medication: Metformin 500mg
Outcome Prediction Moderate

AI model predicts 78% probability of achieving target BP (<130/80 mmHg) within 8 weeks with Amlodipine monotherapy. Combination therapy may be required.

Confidence: 78% | Model: ClinicalBERT v3.2